Last reviewed · How we verify
XS005 Sorafenib Capsule A - Period 2 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
XS005 Sorafenib Capsule A - Period 2 (XS005 Sorafenib Capsule A - Period 2) — Xspray Pharma AB.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| XS005 Sorafenib Capsule A - Period 2 TARGET | XS005 Sorafenib Capsule A - Period 2 | Xspray Pharma AB | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- XS005 Sorafenib Capsule A - Period 2 CI watch — RSS
- XS005 Sorafenib Capsule A - Period 2 CI watch — Atom
- XS005 Sorafenib Capsule A - Period 2 CI watch — JSON
- XS005 Sorafenib Capsule A - Period 2 alone — RSS
Cite this brief
Drug Landscape (2026). XS005 Sorafenib Capsule A - Period 2 — Competitive Intelligence Brief. https://druglandscape.com/ci/xs005-sorafenib-capsule-a-period-2. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab